在患有帕金森病的家庭中发现的α-synuclein基因突变
M H Polymeropoulos1, C Lavedan, E Leroy
1Laboratory of Genetic Disease Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-1430, USA.
概括
研究人员在家族病例中确定了一种与帕金森病 (PD) 相关的特定α-synuclein基因突变. 这一发现有助于理解神经退行性疾病的潜在机制.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,影响大约2%的人口.
- 家庭聚合模式表明PD的遗传成分.
- 之前的研究将PD易感基因定位到意大利一家人的染色体4上.
研究的目的:
- 在受影响的家庭中识别导致帕金森病的特定基因突变.
- 为了研究α-synuclein基因在PD病理生理学中的作用.
主要方法:
- 在一个大意大利亲属的遗传联系分析.
- 对α-synuclein基因的突变查.
- 分析了三个非相关的希腊家族,这些家族都患有自体主导性PD.
主要成果:
- 在意大利亲属中发现了α-synuclein基因的突变.
- 同样的突变在三个无关联的希腊家族中被发现,这些家庭具有自体主导的PD.
- 阿尔法-同核素编码了一个涉及神经元可塑性的前突触蛋白.
结论:
- 一种特定的α-synuclein基因突变与家族性帕金森病有关.
- 这一发现为了解PD病理生理学提供了分子基础.
- 鉴定的突变促进了对PD机制的进一步研究.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


